Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BMP Pharma Trading AGSTU:BMP 36 Return-on-Tangible-Equity is 10.84% as of Dec. 2025, which is 14% below its 10-year median of 12.63. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, BMP Pharma Trading AG ranks better than 79.46% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. BMP Pharma Trading AG's annualized net income for the quarter that ended in Dec. 2025 was €0.96 Mil. BMP Pharma Trading AG's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €8.90 Mil. Therefore, BMP Pharma Trading AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 10.84%.
The historical rank and industry rank for BMP Pharma Trading AG's Return-on-Tangible-Equity or its related term are showing as below:
STU:BMP'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -0.12 Med: 12.63 Max: 35.61
Current: 27.83
During the past 13 years, BMP Pharma Trading AG's highest Return-on-Tangible-Equity was 35.61%. The lowest was -0.12%. And the median was 12.63%.
STU:BMP's Return-on-Tangible-Equity is ranked better than 79.46% of 112
companies
in the Medical Distribution industry
Industry Median: 8.755
vs STU:BMP: 27.83
BMP Pharma Trading AG (STU:BMP) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
BMP Pharma Trading AG Return-on-Tangible-Equity Related Terms
BMP Pharma Trading AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for BMP Pharma Trading AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BMP Pharma Trading AG Return-on-Tangible-Equity Chart
STU:BMP vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, BMP Pharma Trading AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BMP Pharma Trading AG Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where BMP Pharma Trading AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 10.84% mean?
BMP Pharma Trading AG (STU:BMP) has a Return-on-Tangible-Equity of 10.84% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on BMP Pharma Trading AG and its competitors. This is 14% below median its historical median of 12.63. According to the industry distribution chart, BMP Pharma Trading AG ranks #23 out of 112 companies in the Medical Distribution industry, placing it in the top 20.5%.
Is BMP Pharma Trading AG's Return-on-Tangible-Equity too high?
BMP Pharma Trading AG's current Return-on-Tangible-Equity of 10.84% is 14% below median its 10-year median of 12.63. The Medical Distribution industry median Return-on-Tangible-Equity is 8.76. BMP Pharma Trading AG's value of 10.84% is 23.8% above this industry median. Based on the distribution chart, BMP Pharma Trading AG ranks #23 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, BMP Pharma Trading AG ranks #23 out of 112 companies for Return-on-Tangible-Equity. This places BMP Pharma Trading AG in the top 21% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 8.76. BMP Pharma Trading AG's value of 10.84% is 23.8% above this benchmark. While the company's 10-year median is 12.63 vs. the industry median of 8.76, BMP Pharma Trading AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.76, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BMP Pharma Trading AG's current Return-on-Tangible-Equity of 10.84% is 23.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on BMP Pharma Trading AG and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BMP Pharma Trading AG's current Return-on-Tangible-Equity is 10.84%, which is 14% below median its own 10-year median of 12.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current Return-on-Tangible-Equity of 10.84%. The current Return-on-Tangible-Equity is 10.84%, which is 14% below median its 10-year median of 12.63 and 23.8% above the Medical Distribution industry median of 8.76. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current Return-on-Tangible-Equity is 10.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score
Get the complete analysis for STU:BMP
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BMP has been successfully added to your 
